Other articles of interest

Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry

Manuel Gómez-Bueno, Enrique Pérez de la Sota, Alberto Forteza Gil, Daniel Ortiz-Berbel, Javier Castrodeza, María Dolores García-Cosío Carmena, Eduardo Barge-Caballero, Diego Rangel Sousa, Beatriz Díaz Molina, Rebeca Manrique Antón, Luis Almenar-Bonet, Aitor Uribarri González, Alfredo Barrio-Rodríguez, María Ángeles Castel Lavilla, Laura López-López, David Dobarro Pérez, Francisco Pastor Pérez, Virginia Burgos-Palacios, Jesús Álvarez-García, José Manuel Garrido-Jiménez, Óscar González-Fernández, Pau Codina, Amador López-Granados, Andrés Grau-Sepulveda, José González-Costello,

Rev Esp Cardiol. 2023;76:227-37
Efficacy and safety of SGLT2 inhibitors in patients with heart failure according to kidney function: a systematic review and meta-analysis

David Hong, Minseok Hong, Onyou Kim, Heayoung Shin, Minjung Bak, Darae Kim, Jihoon Kim, Ki Hong Choi, Eun Kyoung Kim, Joo Myung Lee, Jeong Hoon Yang, Sung-A Chang, Sung-Ji Park, Sang-Chol Lee, Seung Woo Park, Jin-Oh Choi,
NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification?

Fabian Tran, Francisco Javier Ruperti-Repilado, Philip Haaf, Pedro Lopez-Ayala, Matthias Greutmann, Markus Schwerzmann, Judith Bouchardy, Harald Gabriel, Dominik Stambach, Juerg Schwitter, Kerstin Wustmann, Michael Freese, Christian Mueller, Daniel Tobler,

Rev Esp Cardiol. 2025;78:107-16